ProCE Banner Activity

Multiple Myeloma Care Is Changing, and the Treatment Decision Support Tool Is Keeping Pace

Clinical Thought

Read this expert commentary for an overview of our updated treatment decision support tool for multiple myeloma, which provides current treatment recommendations from 5 experts for your patients with multiple myeloma.

Released: June 22, 2023

Share

Faculty

Joseph Mikhael

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor
Applied Cancer Research and Drug Discovery 
Translational Genomics Research Institute 
Phoenix, Arizona
Chief Medical Officer
International Myeloma Foundation 
HonorHealth Research Institute 
Scottsdale, Arizona

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Bristol Myers Squibb

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.

Partners

Smart Patients

ProCE Banner

Disclosure

Primary Author

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor
Applied Cancer Research and Drug Discovery 
Translational Genomics Research Institute 
Phoenix, Arizona
Chief Medical Officer
International Myeloma Foundation 
HonorHealth Research Institute 
Scottsdale, Arizona

Joseph Mikhael, MD, MEd, FRCPC, FACP: consultant/advisor/speaker: Amgen, Bristol-Myers Squibb, Janssen, Karyopharm, Sanofi, Takeda.